VONZAI
A Real-World Evidence Study to Evaluating the Effectiveness, Safety, and Usage of Vonoprazan in Routine Clinical Practice
BASIC DETAILS
Eligibility of the subjects
Please tick as applicable
| Yes | No | |
|---|---|---|
| Male or female subjects within the age group 18 or above |
|
|
| Subject Diagnosed with GERD, peptic ulcer disease, or other approved indications for Vonoprazan. |
|
|
| Prescribed Vonoprazan as part of routine clinical care. |
|
|
| Available clinical records and follow-up data. |
|
|
Demographic data
Diagnosis and treatment details
Baseline symptoms (Before use of Vonoprazan)
Post treatment symptoms
Patient-Reported Outcomes
Quality of life assessment (If applicable)
--}} {{--Symptom Relief
Overall Satisfaction with Treatment